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Copenhagen, Copenhagen, Denmark
Bacterial resistance to classical antibiotics is emerging worldwide. The number of
infections caused by multidrug resistant bacteria is increasing and becoming a serious
threat for human health globally. In particular, Gram-negative pathogens including
multidrug resistant Escherichia coli are of serious concern being resistant to the currently
available antibiotics. All Gram-negative bacteria are enclosed by an outer membrane
which acts as an additional protection barrier preventing the entry of toxic compounds
including antibiotics and antimicrobial peptides (AMPs). In this study we report that
the outer membrane component lipopolysaccharide (LPS) plays a crucial role for the
antimicrobial susceptibility of E. coli BW25113 against the cationic AMPs Cap18, Cap11,
Cap11-1-18m2, melittin, indolicidin, cecropin P1, cecropin B, and the polypeptide
antibiotic colistin, whereas the outer membrane protease OmpT and the lipoprotein Lpp
only play a minor role for the susceptibility against cationic AMPs. Increased susceptibility
toward cationic AMPs was found for LPS deficient mutants of E. coli BW25113 harboring
deletions in any of the genes required for the inner part of core-oligosaccharide of the
LPS, waaC, waaE, waaF, waaG, and gmhA. In addition, our study demonstrates that the
antimicrobial activity of Cap18, Cap11, Cap11-1-18m2, cecropin B, and cecropin P1 is
not only dependent on the inner part of the core oligosaccharide, but also on the outer
part and its sugar composition. Finally, we demonstrated that the antimicrobial activity
of selected Cap18 derivatives harboring amino acid substitutions in the hydrophobic
interface, are non-active against wild-type E. coli ATCC29522. By deleting waaC, waaE,
waaF, or waaG the antimicrobial activity of the non-active derivatives can be partially or
fully restored, suggesting a very close interplay between the LPS core oligosaccharide
and the specific Cap18 derivative. Summarizing, this study implicates that the nature
of the outer membrane component LPS has a big impact on the antimicrobial activity
of cationic AMPs against E. coli. In particular, the inner as well as the outer part of the
core oligosaccharide are important elements determining the antimicrobial susceptibility
of E. coli against cationic AMPs.
Keywords: antimicrobial peptides, Cap18, Lpp, OmpT, lipopolysaccharide
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INTRODUCTION
The rapid emergence of bacterial resistance to classical antibiotics
is occurring worldwide. The number of infections which are
caused by multidrug resistant bacteria is increasing and bacterial
infections have again become a threat. It’s estimated that bacterial
infections caused by multidrug resistant bacteria result in 25,000
deaths each year in Europe. In the USA, more than 2 million
people are infected with antibiotic-resistant bacteria per year
and 23,000 people are dying as a direct cause (Davies et al.,
2013; World Health Organization, 2014). In particular, infections
caused by Gram-negative bacteria which are resistant to almost
all currently available drugs are of special concern. Multi-drug
resistant Gram-negative bacteria are a great health threat due to
limited treatment options. The pipeline for the development of
new, efficient antimicrobials specifically targeting Gram-negative
bacteria stays empty, despite the increasing number of multidrug
resistant bacteria (Hampton, 2013). In particular, multidrug
resistance in Enterobacteriaceae such as extended-spectrum β-
lactamase (ESBL) and carbapenemase-producing Escherichia coli
are of serious concern being resistant to the currently available
antibiotics (Kanj and Kanafani, 2011; Antibiotics Currently in
Clinical Development, 2014).
In contrast to Gram-positive bacteria, all Gram-negative
bacteria are surrounded by an additional membrane, the so-
called outer membrane (OM) (Figure 1). Unlike the cytoplasmic
membrane, the OM is highly asymmetric, with an inner leaflet
containing phospholipids, and an outer leaflet mainly composed
of lipopolysaccharides (LPS). LPS of Gram-negative bacteria,
including E. coli consists of three parts (Figure 1): (i) lipid A, the
hydrophobic membrane anchor forming the outer leaflet of the
OM, (ii) a phosphorylated, non-repetitive core oligosaccharide
(core-OS) and therefore of highly anionic nature, and (iii) a
O-antigen (O polysaccharide) made of a chain of several types
of repeating sugar units acting as a hydrophilic coating surface
(Erridge et al., 2002; Raetz and Whitfield, 2002). Lipid A is
highly conserved among Gram-negative bacteria, in contrast
to the O-antigen, which is highly flexible. The core-OS of
E. coli is divided into an inner region composed of 2-keto-3-
deoxy-D-manno-octulosonic acid (Kdo) and one or more L-
glycero-D-manno-heptose residues and the outer region made
of various linked sugar residues. The principal features of the
inner region of the core-OS are conserved among members of
the Enterobacteriaceae, which presumably reflects it’s critical role
in OM stability (Caroff and Karibian, 2003). In E. coli, the inner
core region of the core-OS can be further modified with variable
non-stochiometric substitution depending on the core-OS type
(Heinrichs et al., 1998b). The outer region of the core-OS shows
more variability which defines the five different core types in
E. coli (K12, R1, R2, R3, and R4) (Figure 2). All core types share
the structural theme with a (hexose)3 carbohydrate backbone and
two side chain residues. However, the order of the hexose residues
and the position, nature and linkage of the side chain varies from
each core type (Figure 2). Most clinical isolates of E. coli have a
smooth LPS (S-LPS) which consists of all three parts including
the O-antigen, whereas E. coli with rough LPS (R-LPS) lacks the
O-antigen and can even have a truncated core-OS (deep rough).
The minimal LPS essential for growth consists of the Lipid A
and Kdo (3-deoxy-D-manno-oct-2-ulosonic acid) (Frirdich and
Whitfield, 2005).
The OM is essential for cell viability and serves as permeability
barrier preventing the entry of harmful toxic compounds (Savage,
2001; Raetz and Whitfield, 2002; Nikaido, 2003). The overall
composition and structure of the OM are widely conserved
with only little variation among different species (Vaara, 1992).
LPS—being the major component of the outer leaflet of the
OM—plays a central role for the integrity and the selective
permeability of the OM. Charged macromolecules are unable
to penetrate the OM, while many hydrophobic molecules are
allowed limited diffusion (Nikaido, 2003). LPS, in particular the
core-OS plays an important factor in providing selectivity to
hydrophobic molecules. Due to the anionic phosphate groups
in the inner region of the core-OS, LPS molecules are able to
form intermolecular electrostatic bonds with neighboring LPS
molecules via divalent cations, mainly Mg2+ and Ca2+(Vaara,
1992). This cross-bridging of neighboring LPS molecules
significantly contributes to the resistance against hydrophobic
antimicrobial agents. The anionic nature of lipid A and the inner
region of the core-OS seem to be the Achilles heel for the OM
integrity (Schneck et al., 2010).
However, the OM of E. coli consists not only of LPS, but
also of other components such as outer membrane proteins
and lipoproteins (Figure 1). Lpp or murein-lipoprotein is the
most abundant lipoprotein of E. coli and it is estimated to be
numerically the most abundant protein with more than 500,000
molecules per cell (Vaara, 1992; Neidhardt and Umbarger, 1996).
Lpp consists of 58 amino and exists in two forms, (i) the “bound
form”, in which Lpp is covalently bound to the peptidoglycan
layer via the ε-amino group of the C-terminal lysine (Nikaido,
1996) and (ii) the “free form” (Braun and Rehn, 1969; Braun
and Wolff, 1970; Braun and Bosch, 1972). The function of the
free from is not understood, however it has been shown that the
“free from” is exposed to the surface by its C-terminus (Cowles
et al., 2011). The “bound form” of Lpp is an important structural
component in maintaining the stability and integrity of the OM.
Cells lacking Lpp show several OM defects such as increased OM
permeability to small, toxic molecules and antibiotics and leakage
of periplasmic contents (Hirota et al., 1977; Suzuki et al., 1978).
Antimicrobial peptides (AMPs) are recapturing attention
as a potential alternative to classical antibiotics fighting
bacterial infections, including infections caused by Gram-
negative pathogens. Cationic antimicrobial peptides represent
the biggest class of AMPs and are present in virtually all
groups of organisms such as bacteria, fungi, plants, and animals.
Cationic AMPs are characterized by a positive charge and a
hydrophobic region, but their sizes, sequences and secondary
structures vary widely. It is widely believed, that the positive
charge of cationic AMPs enables electrostatic interaction to the
negatively charged microbial membranes (Yeaman and Yount,
2003; Jenssen et al., 2006) and that the hydrophobic region
is involved in the penetration of the cells (Aoki and Ueda,
2013).
The aim of our work is to investigate the antimicrobial activity
of selected cationic AMPs against Gram-negative bacteria, in
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FIGURE 1 | General structure of the cell envelope of Escherichia coli K-12. Schematic view of the cell envelope of E. coli K-12.
particular E. coli. In particular we have studied the potential
role of the outer membrane which performs a crucial role of
providing an extra layer of protection acting as a selective barrier.
More specifically, we analyzed the potential role of particular
components of the OM such as LPS, Lpp, and OmpT, an outer
membrane protease, in the antimicrobial activity of cationic
AMPs. We measured the minimal inhibitory concentration
of the cationic AMPs Cap18, Cap11, Cap11-1-18m2, melittin,
indolicidin, cecropin P1, and cecropin B against E. coli BW25113
(K12) and isogenic mutants defective either in LPS components,
Lpp, or OmpT. Further, we analyzed the susceptibility of
E. coli F470, E. coli F632, E. coli F653, and E. coli F2513,
representing the R1, R2, R3, or R4 prototypes, against the selected
cationic AMPs. Finally, we investigated the mode of action of
Cap18 by analyzing the antimicrobial activity of selected Cap18
derivatives against wild-type E. coli ATCC25922 as well as LPS
mutants.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
All strains used in this study are listed in Table 1. The E. coli
strains 470, F632, F653 and F2513 were kindly provided by
Prof. H. Brade and Prof. S. Muller-Loennies, Research Center
Borstel, Leipniz-Center for Medicine and Biosciences, Germany.
E. coli BW25113 (CGSC#:7636), a derivative of F−, λ− E. coli
K12 strain BD792 is the wild-type strain which was used in
the generation of the KEIO collection and ordered from the
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FIGURE 2 | Structure of the core-OS of Escherichia coli. (A) Structure of the inner region of the core-OS of the E. coli core types. Dashed lines indicate
non-stoichiometric substitutions and the distinguishing modifications of different core types are indicated. (B) Structure of the outer region of the core-OS of the R1,
R2, R3, R4, and K-12 core types. Glc, glucose; GlcN, glucosamine; Hep, L-glycero-D-manno-heptopyranose; Kdo, 3-deoxy-D-manno-oct-2-ulosonic acid; Rha,
rhamonse; Gal, galactose; GlcNAc, N-acetylglucosamine; PEtN, phosphorylethanolamine.
Coli Genetic Stock Centre (CGSC, Yale University). E. coli
JW3596, E. coli JW3024, E. coli JW3595, E. coli JW3606, E. coli
JW0212, E. coli JW1667, E. coli JW0554, E. coli JW3605 and
E. coli JW3600 are isogenic mutants of waaC, waaE, waaF,
waaG, gmhA (lpcA), lpp, ompT, waaP, or waaY derived from
the parental strain E. coli BW25113 and were ordered from
the KEIO collection (Baba et al., 2006). E. coli ATCC25922 is
a clinical isolate, serotype O6, often used as control strain in
antimicrobial susceptibility testing was ordered from the ATCC
strain collection. All strains were grown in Mueller-Hinton-
II medium and incubation took place aerobically at 37◦C for
18–20 h.
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TABLE 1 | Bacterial strains used in this study.
Strain Relevant
characteristics/genotype
References
E. coli F470 E. coli R1 prototype; R-LPS
derivative of O8:K27
Schmidt et al., 1969;
Vinogradov et al., 1999
E. coli F632 E. coli R2 prototype; R-LPS
derivative of O100:K? (B):H2
Hämmerling et al., 1971;
Heinrichs et al., 1998a
E. coli F653 E. coli R3 prototype; R-LPS
derivative of O100
Schmidt et al., 1970
E. coli F2513 E. coli R4 prototype; R-LPS
derivative of O14:K7
Schmidt et al., 1974
E. coli BW25113 F-, 1(araD-araB)567,
1lacZ4787(::rrnB-3), λ-, rph-1,
1(rhaD-rhaB)568, hsdR514
wild-type strain used in the KEIO
collection
Datsenko and Wanner,
2000; Baba et al., 2006
E. coli JW3596 E. coli BW25113 waaC::kan Baba et al., 2006
E. coli JW3024 E. coli BW25113 waaE::kan Baba et al., 2006
E. coli JW3595 E. coli BW25113 waaF::kan Baba et al., 2006
E. coli JW3606 E. coli BW25113 waaG::kan Baba et al., 2006
E. coli JW0212 E. coli BW25113 gmhA::kan
(lpcA::kan)
Baba et al., 2006
E. coli JW1667 E. coli BW25113 lpp::kan Baba et al., 2006
E. coli JW0554 E. coli BW25113 ompT::kan Baba et al., 2006
E. coli JW3605 E. coli BW25113 waaP::kan Baba et al., 2006
E. coli JW3600 E. coli BW25113 waaY::kan Baba et al., 2006
E. coli ATCC25922 Clinical isolate, Serotype O6,
Biotype 1, control strain for
antimicrobial susceptibility
testing
ATCC strain collection
E. coli AD120 E. coli ATCC25922 1waaC Ebbensgaard et al.,
2015
E. coli AD121 E. coli ATCC25922 1waaE Ebbensgaard et al.,
2015
E. coli AD122 E. coli ATCC25922 1waaF Ebbensgaard et al.,
2015
E. coli AD123 E. coli ATCC25922 1waaG Ebbensgaard et al.,
2015
Antimicrobial Peptides
The amino acid sequence, origin and structure of cecropin
P1, cecropin B, Cap18, Cap11, Cap11-1-12m2, melittin, and
indolicidin are summarized in Table 2. Cecropin B, cecropin
P1 and colistin sulfate (C4461) were purchased from Sigma-
Aldrich. Cecropin B with a purity of ≥97% and cecropin P1 with
a purity of ≥95% and were dissolved in water. Colistin sulfate
was dissolved in water. Cap11 (94.7% purity), Cap11-1-18m2
(87.9% purity) and Cap18 (89.5% purity) were synthesized at
Genscript. Cap18 and Cap11 were dissolved in DMSO, Cap11-1-
18m2 was dissolved in water. Melittin (RP10290) and indolicidin
(RP11242-0.5) each with a purity of >95% were purchased
from Genscript and dissolved in water. The Cap18 derivatives
used in this study were purchased as chemically synthesized
peptides with high purity from Genscript or Peptide 2.0. The
amino acid sequence and purity of each Cap18 derivative is
summarized in Table 6. All peptides were dissolved to a stock
concentration of 10 mg/ml, except colistin sulfate which was
dissolved to a stock concentration of 50 mg/ml and stored
at−20◦C.
Antimicrobial Susceptibility Testing (MIC
Testing)
The minimum inhibitory concentrations (MICs) of the AMPs
were measured in 96-well microtiter plates according the Clinical
and Laboratory Standards Institute [CLSI, formerly National
Committee for Clinical Laboratory Standards (NCCLS)] (Wikler
et al., 2009). Liquid Mueller-Hinton-II medium containing
increasing concentrations of AMPs is inoculated with a defined
number of cells (∼105 CFUs/ml) in 96-well microtiter plates
(polypropylene). Each microtiter plate includes a positive growth
control and a negative control (sterile control). After incubation,
theminimal inhibitory concentration (MIC) is determined by the
lowest concentration showing no visible growth. All plates were
incubated for 16–20 h.
RESULTS
OmpT Has No or Minor Influence on the
Antimicrobial Activity of Cationic AMPs in
the Escherichia coli K12 BW25113
OmpT, a member of the aspartyl proteases, is found in the
outer member of E. coli and is responsible for the cleavage of
peptides and proteins between two consecutive basic amino acid
residues (Sugimura and Nishihara, 1988; Kramer et al., 2000,
2001). Previously, it was shown that an E. coli 1ompT mutant
is hypersusceptible to the AMP protamine (Stumpe et al., 1998),
and that OmpT of enterohaemorrhagic E. coli (EHEC) cleaves
LL-37, the human homolog of Cap18 (Thomassin et al., 2012).
In order to assess the role of OmpT in the K12 E. coli BW25133,
we investigated the antimicrobial activity of seven cationic AMPs
from different classes and origins as well as the antibiotic
colistin against the ompT mutant which was selected from the
KEIO collection (Baba et al., 2006). The antimicrobial activity
was measured as minimal inhibitory concentration (MIC) and
summarized in Table 3. The activity of the cathelicidin Cap18, a
homolog of LL-37 is not affected in the ompT mutant compared
to the parental strain BW25113 (Table 3). Cap11, another
member of the cathelicidin family, is slightly more active, up to
factor 2, in the ompT mutant strain compared to the wild-type
strain. However, the MIC of Cap11-1-18m2, a shorter derivative
of Cap11 is unchanged in the ompT background. Similar to
Cap11, the antimicrobial activity of cecropin B and cecropin
P1 is increased up to factor 2. In contrast, the antimicrobial
activity of indolicidin is not affected in and melittin is slightly
less effective (up to factor 2) in an ompT mutant background.
The antimicrobial activity of the polypeptide antibiotic colistin
is unchanged in the ompT mutant. The solvent DMSO had
no antimicrobial activity in the concentrations used in the
MIC assays (data not shown). Based on these results, we can
suggest that the outer membrane protease OmpT has no or
only a minor impact on the antimicrobial activity of cationic
AMPs.
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TABLE 2 | Cationic antimicrobial peptides used in this study: sequence, origin, and structure.
Peptide Sequence Origin Structure
Cap18 GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY Mammalian, rabbit, neutrophils α-helical
Cap11 GLRKKFRKTRKRIQKLGRKIGKTGRKVWKAWREYGQIPYPCRI Mammalian, guinea pig, neutrophils α-helical
Cap11-1-18m2 KLRKLFRKLLKLIRKLLR Truncated derivative of Cap11
Cecropin P1 SWLSKTAKKLENSAKKRISEGIAIAIQGGPR Mammalian, pig, small intestine α-helical
Cecropin B KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKALG-NH2 Insects, giant silk moth, pupae α-helical
Melittin GIGAVLKVLTTGLPALISWIKRKRQQ-NH2 Insects, honey bee α-helical
Indolicidin ILPWKWPWWPWR-NH2 Mammalian, bovine neutrophils extended
TABLE 3 | Susceptibility of E. coli BW25113 mutants deficient in outer membrane to cationic antimicrobial peptides.
Cap18 Cap11 Cap11-1-18 m2 Melittin Indolicidin Cecropin P1 Cecropin B Colistin
E. coli BW25113 4–8 8 8–16 16–32 32 16–32 16–32 0.125–0.25
E. coli BW25113 waaC::kan 4 8 8 4 16 8 8 0.063–0.125
E. coli BW25113 waaE::kan 4 8 8 4 16 8 8 0.063–0.125
E. coli BW25113 waaF::kan 4 8 8 4 16 4 4 0.063
E. coli BW25113 waaG::kan 4 8 8 4 16 16 16 0.063–0.125
E. coli BW25113 gmhA::kan 4–8 8* 8* 2* 16* 4–8* 4–8* 0.063
E. coli BW25113 ompT::kan 4–8 4–8* 8* 32* 32* 16* 16* 0.125–0.25
E. coli BW25113 lpp::kan 2–4* 8* 8–16* n.d. n.d. n.d. 16* 0.063–0.125
E. coli BW25113 waaP::kan 4–8 8–16 n.d. 4 32 16–32 32 0.125–0.25
E. coli BW25113 waaY::kan 4–8 8–16 n.d. 16–32 32 32 32–64 0.125–0.25
Data are collected as minimal inhibitory concentrations (MICs) according to the Clinical and Laboratory Standards Institute (CLSI) and expressed in µg/ml. All MIC determinations were
carried out in duplicates* or in triplicates. n.d., not determined.
Susceptibility Testing of E. coli BW25113
lpp::kan to Cationic Antimicrobial Peptides
Although it is known that the deletion of the lpp gene leads to
increased drug susceptibility, the antimicrobial activity pattern
of cationic AMPs has not been analyzed in a more detailed
manner using isogenic strains. To investigate the potential role
of Lpp on the antimicrobial activity of cationic AMPs, the
BW25133 lpp::kanmutant was selected from the KEIO collection
and tested for antimicrobial susceptibility. Due to the limited
amounts of available peptide, only Cap18, Cap11, Cap11-1-12m2,
cecropin B and colistin were tested for antimicrobial activity
in the lpp mutant (Table 3). The MIC values for cecropin B,
Cap11 and Cap11-1-12m2 were unchanged in the lpp mutant
strain compared to the wild-type. Only, for Cap18 and colistin,
a minimal increase of factor 2 in the antimicrobial susceptibility
could be detected. Based on our results, we can conclude that
Lpp is not playing a central role for the antimicrobial activity
of the majority of the tested cationic AMPs. Only for Cap18
and colistin, Lpp plays a marginal role for the antimicrobial
activity.
Increase of Antimicrobial Susceptibility to
Cationic Antimicrobial Peptides in LPS
Deficient E. coli Mutants
To understand the effect of LPS, in particular the core-OS,
on the antimicrobial activity of cationic AMPs, several LPS
mutants were selected from the KEIO collection and analyzed
for antimicrobial susceptibility. Three different sets of LPS
mutants were chosen, one set of mutants harboring deletions of
genes involved in the assembly of the LPS molecule including
glycosyl- and heptosyltransferases (waaC, waaF, and waaG),
one set containing LPS modifying enzymes such as the LPS
kinases waaP and waaY, and third set consisting of mutants
deficient in the synthesis of ADP-heptose (gmhA and waaE)
which is the precursor to the LPS heptose molecule. The MIC
of Cap18, Cap11, Cap11-1-18m2, melittin, indolicidin, ceropin
P1, cecropin B, and colistin was measured for E. coli BW25113
strains harboring a mutation either in waaG, waaC, waaE, waaF,
or gmhA, all genes required for the core-OS of the LPS, and
the wild-type strain BW25113. The MIC values are summarized
in Table 3. Except for Cap11, all the tested cationic AMPs
showed higher antimicrobial activity against the waaC, waaF,
waaG, waaE, and gmhAmutants compared to the parental strain
BW25113. The highest increase (8- to 16-fold) in antimicrobial
activity was measured for melittin against BW25113 gmhA::kan.
In addition, the susceptibility of BW25113 waaC::kan, BW25113
waaF::kan, BW25113 waaG::kan and BW25113 waaE::kan, was
increased by a factor 4–8 compared to the wild-type strain.
Cecropin P1 and cecropin B are more active in the LPS mutant
backgrounds; 4–8x more active in a waaF::kan background, 4x
more active in gmhA::kan background, 2–4x more active in
waaC::kan and waaE::kan background and up to 2-fold more
active in the waaG::kan background compared to the parental
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BW25113 strain. Indolicidin is twice as active and Cap11-1-
18m2 shows a small increase of up to 2-fold in antimicrobial
activity in all the LPS mutants tested compared to the wild-
type strain. Similarly, deletions of waaC, waaE, waaF and
waaG show a slightly increased susceptibility (up to 2-fold)
against Cap18. In comparison, the polypeptide antibiotic colisitin
exhibited a slightly increased antimicrobial activity (up to factor
2) against waaC, waaF, waaG, waaE, and gmhA mutants. In
addition to the enzymes directly involved in the synthesis of the
core oligosaccharide, we analyzed the effect of LPS modifying
enzymes such as the LPS kinase waaP and waaY responsible
for the phosphorylation of heptose I and heptose II. WaaP
is phophorylating the heptose I residue, whereas waaY is
responsible for the phosphorylation of the heptose II residue.
However, in waaP mutant both sugar residues, heptose I and
heptose II, remain unphosphorylated (Yethon et al., 1998). The
antimicrobial susceptibility of a waaP mutant is not changed
for Cap18, Cap11, cecropin B, cecropin P1, indolicidin and
colistin. Only melittin is 4–8 times more active in a waaPmutant
background compared to the wild-type strain. Inactivating waaY
had no effect on the activity of Cap18, Cap11, cecropin P1,
melittin, and indolicidin, whereas cecropin B was slightly less
active (up to factor 2). Based on our results, we can conclude
that LPS, in particular the sugar structure of the core-OS plays an
important role for the antimicrobial activity of cationic AMPs.
However, the gain of antimicrobial activity of tested AMPs
against the individual LPS mutants is highly dependent on the
nature of the AMP itself. The antimicrobial activity of Cap18,
Cap11, and Cap11-1-18m2, all members of the cathelicidin
family, is not or only marginal affected in all the tested LPS
mutants compared to wild-type, whereas melittin is 4x more
active in any of the tested LPS mutants with truncations in the
sugar backbone. In contrast, the effect of phosphorylation of
the heptose I and heptose II sugar residue is only minor. The
antimicrobial activity of most of the tested AMPs as well as the
polypeptide antibiotic colistin is unchanged in the waaP and
waaY. Only melittin is 4 times more active in a waaP mutant,
but not in a waaY mutant.
The Core Type of Escherichia coli
Determines the Antimicrobial Activity of
Cationic AMPs
To investigate the role of LPS in more detail, we analyzed
the potential role of the different sugar moieties in the outer
part of the core-OS in E. coli. Therefore, we determined the
antimicrobial activity of the selected cationic AMPs against five
E. coli strains representing the five different core types (R1,
R2, R3, R4, and K12). The selected AMPs were tested for
the antimicrobial activity against E. coli ATCC25922, E. coli
BW25113 (K12), E. coli F470 (R1 prototype, rough LPS),
E. coli F632 (R2 prototype, rough LPS), E. coli F653 (R3
prototype, rough LPS) and E. coli F2513 (R4 prototype, rough
LPS). The antimicrobial activity was measured as minimal
inhibitory concentration (MIC) and summarized in Table 4. The
antimicrobial activity of Cap18 is very similar against all the
tested E. coli strains with MIC values of 4–8µg/ml. Only E. coli
F2513 is slightly more susceptible to Cap18 with a MIC value of
2–4µg/ml. The antimicrobial activity of Cap11, another member
of the cathelicidin family, varies 2- to 4-fold depending on the
core type. Cap11 shows highest antimicrobial activity against
E. coli F2513, the R4 prototype. Similarly, Cap11-18m2, a short
derivative of Cap11, is most potent against E. coli F2513. In
contrast to the AMPs from the cathelicidin family, melittin shows
the biggest variation in antimicrobial activity depending on the
core type. The antimicrobial activity of melittin is e.g., 4- to 8-
fold higher against E. coli F2513 (R4 core type) than BW25113
(K12). The MIC value of indolicidin against E. coli F2513 is 4- to
2-fold lower than the MIC values measured for the other strains.
The MIC values measured for cecropin P1 are very similar for
all strains measured indicating that the activity of cecropin P1 is
independent on the core type. Similarly for cecropin B, a slight
variation in MICs (≤2-fold) was measured depending on the
core type. Summarizing, the antimicrobial efficacy of the tested
cationic AMPs varies depending on the E. coli core type. All
the tested cationic peptides are most active against E. coli F2513
which represents the R4 core type. This finding indicates that
the sugar moieties of the outer core region of the core-OS might
play an important role for the antimicrobial activity of cationic
AMPs. However, the individual AMPs differs in their degree of
LPS selectivity. Melittin showed the largest difference in MIC
values ranging from 4 to 32µg/ml depending on the isolate and
core type. In contrast, the MIC values for Cap18 only show a
minimal variation (up to factor 2) depending on the strain. This
suggests that Cap18 targets E. coli in an efficient way regardless of
the core type.
The Antimicrobial Activity of Pattern of
E. coli ATCC25922 Is Similar to Core Type
R1
One of the most frequently used E. coli strains in antimicrobial
susceptibility testing is E. coli ATCC25922. E. coli ATCC25922
is a clinical isolate with a smooth LPS (serotype 6), serves as a
reference strain in antimicrobial susceptibility testing and was
used in a previous study dissecting the antimicrobial activity of
Cap18. The core type of ATCC25922 hasn’t been identified so far.
We measured the antimicrobial activity of the selected cationic
AMPs against E. coli ATCC25922 and compared the MIC value
to BW25311, F470, F632, F653, and F2513 all harboring a rough
LPS and representing the different core types (Table 4). The
antimicrobial susceptibility of ATCC25922 toward all the tested
AMPs is very similar to F470. This indicates that ATCC25922
might be a member of the core type R1.
Restoration of the Antimicrobial Activity of
CAP18 Derivatives by Changing the
Structure of the Inner Core Region of the
LPS
In a previous study, we dissected the antimicrobial activity
of Cap18 and were able to generate Cap18 derivatives with
enhanced species-selective killing (Ebbensgaard et al., 2018).
Together with our current findings demonstrating that the
antimicrobial activity of Cap18 is not or only marginal affected
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TABLE 4 | Antimicrobial activity of selected antimicrobial peptides in Escherichia coli with different LPS core types.
Antimicrobial activity µg/ml
Cap18 Cap11 Cap11-1-18 m2 Melittin Indolicidin Cecropin P1 Cecropin B
E. coli BW25113 (K12) 4–8 8 16–32 16–32 32 16–32 16–32
E. coli F470 (R1) 4 16 32 16 ≥32 32 32
E. coli F632 (R2) 4 8 16–32 32 ≥32 32 16–32
E. coli F653 (R3) 4–8 16 ≥32 32 ≥32 32 32
E. coli F2513 (R4) 2–4 4–8 8–16 4 8–16 16–32 16
E. coli ATCC25922 4 16 32 16 32 32 32
Data are collected as minimal inhibitory concentrations (MICs) according to the Clinical and Laboratory Standards Institute (CLSI) and expressed in µg/ml. All MIC determinations were
carried out in triplicates.
by the presence of the inner core region or by the sugar
composition of the outer region of the core-OS, we decided
to investigate the mechanism of Cap18 and the role of LPS
in more detail. For this analysis, we selected a set of Cap18
derivatives with species-specific killing properties. Based on
our previous study, we selected 12 Cap18 derivatives which
had lost their antimicrobial activity against E. coli ATCC25922
(MIC ≥ 64µg/ml). Each of these 12 derivatives harbors one
single amino acid substitution compared to the original Cap18
peptide. In addition, we selected 8 derivatives exhibiting the
same antimicrobial activity as the original Cap18 peptide
(MIC = 4–8µg/ml) and were included in the study as
control peptides. The amino acid sequences and purities of
the selected Cap18 derivatives are summarized in Table 5.
For all 20 Cap18 derivatives the antimicrobial activity was
investigated measuring the MIC value against E. coliATCC29522
1waaC, E. coli ATCC29522 1waaE, E. coli ATCC29522 1waaF,
E. coli ATCC295221 waaG and the parental strain ATCC29522
(Table 6).
The antimicrobial activity could be fully reconstituted for
four derivatives by deleting any of wwaC, waaE, waaF, or
waaG in the ATCC29522 background. In more detail, Cap18
harboring either a L17K, I20E, I24G or L27P substitution
exhibit no antimicrobial activity against E. coli ATCC29522,
but regained full antimicrobial activity (MIC value: 4–8µg/ml)
in LPS mutants harboring a deletion either in wwaC, waaE,
waaF, or waaG. The Cap18 derivative with a I24N substitution
regained full antimicrobial activity in a waaC and waaF mutant
background compared to ATCC29522 wild-type. However, the
deletion of waaE and waaG only led a partial restoration
of the antimicrobial activity of I24N. Similarly, an I20N
substitution could successfully restore the antimicrobial activity
of Cap18 in a waaF mutant background and partially restore
the activity in 1waaC, 1waaE, and 1waaF. Cap18 I13R was
not active in both the wild-type as well as in the waaE
mutant (MIC≥64µg/ml), however fully active in the waaG
mutant and partially active in the waaF and waaC mutants.
The antimicrobial activity of the Cap18 derivatives harboring
a I13P or I24D substitution, both non-active in ATCC29522,
could only be partially restored by deleting either wwaC, waaE,
waaF, or waaG. Interestingly, Cap18 I13D, L17D and L17P
were non-active against all the tested strains including the
LPS mutants. Cap18 derivatives exhibiting an antimicrobial
activity comparable to the original Cap18 peptide (MIC =
4–8µg/ml), showed either unchanged or slightly improved
(factor 2) antimicrobial activity in the LPS mutants compared
to the original Cap18 peptide (Table 6). Summarizing, we
could demonstrate that changing the LPS structure of E. coli
ATCC25922, in particular the inner region of the core-OS,
can lead to a restoration of the antimicrobial activity of
individual Cap18 derivatives which were not active in the
parental ATCC25922 strain.
DISCUSSION
Bacterial pathogens have evolved different mechanisms to resist
the antimicrobial activity of cationic AMPs (Peschel and Sahl,
2006). The production of proteases degrading and thereby
inactivating cationic AMPs is one obvious way for bacteria to
protect themselves against antimicrobials. Several omptins such
as OmpT, and PgtE, all proteases found in the OM of various
Gram-negative pathogens belonging to the Enterobacteriaceae
family, have been associated with the degradation of AMPs
(Hritonenko and Stathopoulos, 2007). In particular, OmpT has
been implicated in the proteolytic degradation of protamine
and LL-37, the human homolog of Cap18. Measuring the MIC
values for Cap18, melittin and indolicidin no change could
be detected in an ompT mutant background compared the
parental E. coli BW25113. Similarly, only a marginal increase in
antimicrobial activity of Cap11, Cap11-1-18m2, cecropin P1 and
cecropin B was detected in the ompT mutant strain compared
to wild-type. Our data clearly indicate that OmpT only plays
a minor role in protecting E. coli K-12 against cationic AMPs.
This is in agreement with previous studies showing that the
MIC of LL-37, the human homolog of Cap18, is unchanged
in CFT0731ompT compared to the wild-type CFT073, an
uropathogenic E. coli strain (Brannon et al., 2013). Similar
results were observed in EPEC E2348/69, an enteropathogenic
E. coli. The MIC value of LL-37 was unchanged in the 1ompT
mutant compared to the parental strain. For C18G, another
AMP, a slight decrease in MIC (factor 2) was observed in the
1ompT mutant (Thomassin et al., 2012). Even though there
was no or only a minor effect of OmpT on the susceptibility,
it has been demonstrated that OmpT from E. coli CFT073 and
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TABLE 5 | Cap18 derivatives: amino acid sequence, purity, solvent, manufacturer.
Cap18 peptide Amino acid sequence Purity Solvent Company
Cap18-original GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY ≥89.5% DMSO Genscript
L6P GLRKRPRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY 99.9% DMSO Genscript
I13D GLRKRLRKFRNKDKEKLKKIGQKIQGLLPKLAPRTDY 96.59% DMSO Peptide 2.0
I13P GLRKRLRKFRNKPKEKLKKIGQKIQGLLPKLAPRTDY 98.67% DMSO Peptide 2.0
I13R GLRKRLRKFRNKRKEKLKKIGQKIQGLLPKLAPRTDY 95.97% DMSO Peptide 2.0
I13F GLRKRLRKFRNKFKEKLKKIGQKIQGLLPKLAPRTDY 100% DMSO Peptide 2.0
I13H GLRKRLRKFRNKHKEKLKKIGQKIQGLLPKLAPRTDY 97.8% DMSO Genscript
I13M GLRKRLRKFRNKMKEKLKKIGQKIQGLLPKLAPRTDY 100% DMSO Peptide 2.0
K16C GLRKRLRKFRNKIKECLKKIGQKIQGLLPKLAPRTDY 95.8% DMSO Genscript
K16D GLRKRLRKFRNKIKEDLKKIGQKIQGLLPKLAPRTDY 99.84% DMSO Peptide 2.0
L17D GLRKRLRKFRNKIKEKDKKIGQKIQGLLPKLAPRTDY 97.46% DMSO Peptide 2.0
L17K GLRKRLRKFRNKIKEKKKKIGQKIQGLLPKLAPRTDY 96.84% DMSO Peptide 2.0
L17P GLRKRLRKFRNKIKEKPKKIGQKIQGLLPKLAPRTDY 96.26% DMSO Peptide 2.0
K18P GLRKRLRKFRNKIKEKLPKIGQKIQGLLPKLAPRTDY 99.32% DMSO Peptide 2.0
I20E GLRKRLRKFRNKIKEKLKKEGQKIQGLLPKLAPRTDY 99.72% DMSO Peptide 2.0
I20N GLRKRLRKFRNKIKEKLKKNGQKIQGLLPKLAPRTDY 96.95% DMSO Peptide 2.0
I24D GLRKRLRKFRNKIKEKLKKIGQKDQGLLPKLAPRTDY 98.99% DMSO Peptide 2.0
I24G GLRKRLRKFRNKIKEKLKKIGQKGQGLLPKLAPRTDY 96.2% DMSO Genscript
I24N GLRKRLRKFRNKIKEKLKKIGQKNQGLLPKLAPRTDY 99.78% DMSO Peptide 2.0
G26T GLRKRLRKFRNKIKEKLKKIGQKIQTLLPKLAPRTDY 95.05% DMSO Peptide 2.0
L27P GLRKRLRKFRNKIKEKLKKIGQKIQGPLPKLAPRTDY 97.94% DMSO Peptide 2.0
Amino acid substitution is highlighted in bold.
E. coli EPEC E2348/69 mediate degradation of LL-37(Thomassin
et al., 2012; Brannon et al., 2013). The effect of OmpT on the
susceptibility was more pronounced in the enterohemorrhagic
E. coli EHEC EDL933. The MIC values for LL-37 was decreased
by factor 2 and for C18G lowered by factor 8. Altogether, this
indicates that the contribution of OmpT to the degradation
and inactivation of AMPs is in general only marginal, however
also depending on the AMP itself and the nature of the E. coli
strain.
The nature of the cell surface, in particular the composition
of the OM of Gram-negative bacteria has a major impact on
the antimicrobial activity and efficacy of antimicrobial agents
including cationic AMPs. Therefore, we investigated the role
of Lpp, which is the most abundant protein in E. coli being
present either as free surface exposed Lpp, or in bound form
connecting the peptidoglycan with the OM. Recently, it was
demonstrated that Lpp is binding specifically to the α-helical
AMPs such as Cap18, LL-37 and SMAP-29, but not to Polymyxin
B. A model has been suggested in which Lpp acts as receptor
for Cap18, LL-37 and SMAP-29 contributing directly to the
susceptibility of α-helical cationic AMPs (Chang et al., 2012).
However, our data demonstrate that deleting the lpp gene leads
to a slightly increased susceptibility which indicates that Cap18
efficiently kills E. coli BW25113 even in the absence of Lpp.
Based on our findings, we conclude that the presence of Lpp is
not required for the antimicrobial activity of the tested cationic
AMPs such as Cap18, Cap11, Cap11-1-18m2 and cercopin B
against E. coli BW25133. Depleting the cell for both forms of
Lpp, the “free from” which is surface exposed, as well as the
“bound form” with a clearly defined periplasmic function by
deleting the lpp gene might result in a changed OM. Mutants
deficient in total Lpp have been shown to produce OM vesicles
and to leak periplasmic proteins (Hirota et al., 1977). More
recently, the susceptibility pattern of various antibiotics has
been investigated in L51, an E. coli K-12 derivative, and in
the isogenic 1lpp mutant. Similar to our results for cationic
AMPs, the susceptibility was slightly increased for vancomycin,
erythromycin and rifampicin in the 1lpp mutant compared to
the parental strain (Kowata et al., 2016). Even though it has been
demonstrated that Lpp is able to bind α-helical cationic AMPs,
Lpp seems to play only a marginal role for the antimicrobial
susceptibility of E. coli to the cationic AMPs we tested in our
study.
It is well-known that LPS plays a central role in membrane
permeability and therefore a major impact on the antimicrobial
activity of mainly hydrophobic antibiotics (Vaara, 1993; Delcour,
2009). One of the major interests of this study was to elucidate
the role of LPS on the antimicrobial activity of cationic AMPs
focusing on both, the impact of the structure of the inner and
outer region of the core-OS as well as the phosphorylation of the
core-OS. From our findings, we can conclude that changes of the
structure of the inner region of the core-OS have a great impact
on the antimicrobial activity of cationic AMPs and themajority of
the tested AMPs exhibit increased antimicrobial activity in deep
roughmutants of E. coli In E. coli, the inner core-OS regionmight
have a protective function in preventing the binding of cationic
AMPs to the inner core-OS, which is considered as the Achilles
heel of LPS. Binding of cationic AMPs to the inner core-OSmight
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TABLE 6 | Antimicrobial activity of Cap18 derivatives against E. coli ATCC25922 LPS mutants and other Enterobacteriaceae.
Cap18 peptide Antimicrobial activity: MIC µg/ml
E. coli ATCC25922 S. typhimurium LT2 Y. ruckeri 392/2003
Wild-type 1waaC 1waaE 1waaF 1waaG
Cap18-original 4–8 2–4 4 2–4 4 4–8 2–4
L17K ≥64 8 8 8 8 16 ≥64
I20E ≥64 4 4 4 8 8 32
I24G ≥64 8 8 8 8 8–16 32
L27P ≥64 8 4 4 4 8 32
I24N ≥64 8 16 8 16 32 ≥64
I20N ≥64 16 16 8 16 8–16 ≥64
I13R ≥64 32 ≥64 16 8 16–32 32–64
I24D ≥64 16 16 16 ≥64 ≥64 ≥64
I13P ≥64 32 32 16 32 16–32 ≥64
I24D ≥64 16 16 16 ≥64 ≥64 ≥64
I13D ≥64 ≥64 ≥64 ≥64 ≥64 ≥64 ≥64
L17D ≥64 ≥64 ≥64 ≥64 ≥64 ≥64 ≥64
L17P ≥64 ≥64 ≥64 ≥64 ≥64 ≥64 ≥64
I13F 4 2 2 2 2 4 2
I13H 4 2 2 2 2 4 8–16
K16D 4 2 8 2 4 4 4
L6P 8 4 8 4 4 8 64
I13M 8 4 8 4 4 8 4
K16C 8 4 8 4 8 8–16 8–16
K18P 8 2 4 4 4 4 32
G26T 8 4 4 4 4 4–8 2–4
Data are collected as minimal inhibitory concentrations (MICs) according to the Clinical and Laboratory Standards Institute (CLSI) and expressed in µg/ml. All MIC determinations were
carried out in in triplicates.
FIGURE 3 | Predicted structure of Cap18. The structure of Cap18 was predicted using I-Tasser (Roy et al., 2010) and visualized by CCP4 software (McNicholas et al.,
2011). The predicted α-helix is highlighted in red. Hydrophobic residues of the α-helix are shown in green. (A) View along helix axis, (B) view from N- to C-terminal,
(C) view form C- to N-terminal.
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cause enhanced lateral diffusion of the LPS. This is provoked
by the displacement of divalent cations normally stabilizing
neighboring LPS molecules by electrostatic interactions and
leading to increased OM permeability. By deleting the outer
region of the core-OS, the AMPs will get easier access to the
cell membrane, which promotes the penetration of the AMP
by self-promoted uptake. This is in agreement with previous
studies which demonstrated that the outer region of the core-OS
has a protective role against large cationic antimicrobial agents
such as colicin N and that the outer region of the core OS
weakens the non-specific interactions between colicin N and the
membrane surface (Clifton et al., 2016). However, the degree of
increased susceptibility highly depends on the nature of the AMP
itself. The susceptibility of the tested mutants deficient in the
inner core-OS region is e.g., unchanged for Cap11 compared to
the wild-type strain, whereas the same mutants are 4–8 times
more susceptible to melittin compared to the parental strain.
Not only the nature of the AMP, but also the gene which has
been deleted, seems to play a crucial role for the antimicrobial
activity of some AMPs. Example, a waaF mutant exhibits a 4-
to 8-fold increased susceptibility for cecropin P1 and cecropin
B compared to wild-type, whereas a waaG mutant is only up to
2-fold more susceptible. The phosphorylation of the HepI and
HepII sugar residue plays a minor role for the antimicrobial
activity of the majority of tested AMPs, except for melittin.
Only melittin is 4–8 more active in a E. coli lacking all the
phosphate groups in the inner core region. However, it has
been previously demonstrated that a waaY mutant, which is
lacking the phosphate group on HepII, is less susceptible to
LL-37, but not to other AMPs including CRAMP, SMAP-29,
BMAP-27, Bac7, or polymyxin (Bociek et al., 2015). This findings
highly suggests that E. coli with a phosphate-less inner OS-
core region can be more or less susceptible to cationic AMPs
suggesting more specific interactions of the individual AMPs and
the LPS.
In addition, our findings suggest that not only the inner core
region of the core-OS, but also the outer region of the core-OS
is important for the mode of action of cationic AMPs in E. coli.
The composition of the different sugar moieties of the outer
core-OS region determines the antimicrobial activity of some
of the tested cationic AMPs including Cap18, Cap11, Cap11-1-
18m2, melittin, and indolicidin. E. coli F2513 representing the R4
core type is 4–8 time more susceptible for melittin than E. coli
strains representing the K-12, R1, R2, or R3 core type. Similarly,
indolicidin, Cap18, Cap11, and Cap11-1-18m2 are 2-fold more
effective in E. coli F2513. In contrast, for cecropin B as well
as for cecropin P1, the composition of the outer region of the
core-OS has no influence on the antimicrobial activity. Taken
together, these findings clearly indicate that the protective role
of the outer core-OS region depends on the core type and the
different sugar compositions. In order to identify the most potent
AMP against one particular E. coli strain, analyzing the core type
would be advantageous and useful prior to the administration of
AMPs. Previously, a PCR based LPS core typing system has been
developed for E. coli which allows the identification of the core
type (Amor et al., 2000).
As demonstrated previously, Cap18 is highly active against
a broader range of bacterial pathogens including Gram-positive
and Gram-negative bacteria and is a promising candidate for
further applications (Ebbensgaard et al., 2015). In order to better
understand the mode of action and interplay between Cap18
and the OM of E. coli, we investigated the antimicrobial activity
of a selection of Cap18 derivatives in different E. coli mutant
background with a changed inner core-OS region. Our data
shows the importance of LPS for the antimicrobial activity of
Cap18 and demonstrates that some of initially non-active Cap18
derivatives can regain full antimicrobial activity in specific LPS
deficient backgrounds. Based on our results, we can conclude
that an intact hydrophobic face of Cap18 plays a crucial role
for the antimicrobial activity against E. coli ATCC25922, in
particular the hydrophobic residues I13, L17, I20, I24, and L27
(Figure 3). The tested derivatives harboring a substitution in
the hydrophobic face (I13, L17, I20, I24, L27) can be divided
into two different groups. One group exhibits a complete
loss of antimicrobial activity regardless of the LPS structure
and a second group of Cap18 derivatives which were initially
non-active against the wild-type, but regained full or partial
antimicrobial activity in LPS mutants with a changed inner core-
OS. Introducing the negatively charged residue aspartic acid
either at position I13 or L17 destroys the antimicrobial activity
of Cap18 against wild-type and LPS mutants regardless of the
inner core-OS structure. This suggests that the changes of Cap18
provoked by the introduction of a negative charged residue at
a central hydrophobic position have a dramatic effect on the
antimicrobial activity which is in agreement with our previous
study showing that Cap18 I13D and L17D lost activity against
any of the tested organisms, regardless if Gram-positive or Gram-
negative (Ebbensgaard et al., 2018). Similarly, the introduction
of a proline residue at position L17 will lead to a complete loss
of antimicrobial activity. In contrast, the antimicrobial activity of
Cap18 I13R, in which a hydrophobic residue is substituted by the
positively charged arginine, can be reestablished in deep rough
mutants. Interestingly, the degree of antimicrobial activity of
Cap18 I13R highly depends on the kind of LPS mutation, which
suggests that the length of the LPS truncation determines the
antimicrobial activity of Cap18 I13R. A LPS mutant only missing
the outer region of the core-OS is the more susceptible than a
heptoseless mutant only consisting of the minimal Kdo2-LipidA
unit. Similarly, the antimicrobial activity of Cap18 L17K can
be partially regained by changing the inner core-OS structure.
Interestingly, the very same derivative was shown to exhibit
species-specific antimicrobial activity only killing P. aeruginosa,
but not targeting Y. ruckeri, L. lactis, and E. faecalis (Ebbensgaard
et al.). These findings suggest that the antimicrobial activity
of Cap18 L17K is dependent on the structure of the bacterial
cell wall. Similarly, derivatives with either an I20E, I20N, I24G,
I24N, or L27P substitution, initially inactive against wild-type
E. coli, are regaining full or partial activity by changing the LPS
structure. To summarize, we suggest a close interplay between
LPS and Cap18 which is very specific for the tested Cap18
derivative and highly dependent on the structure of the inner
core-OS.
Frontiers in Microbiology | www.frontiersin.org 11 September 2018 | Volume 9 | Article 2153
Ebbensgaard et al. Lipopolysaccharides Determine Sensitivity to AMPs
AUTHOR CONTRIBUTIONS
AE, EH, and FA have conceived the study, were in charge of
the overall study design and took part in the project discussions.
AE and HM have performed all experimental work. AE and EH
composed the manuscript. AE, HM, FA, and EH contributed to
manuscript revision and approved the submission.
FUNDING
The research was made possible through financial support from
the Danish Ministry of Food, Agriculture and Fisheries program
supporting Green Development and Demonstration (GUDP
grant nr.: 3405-10-0124) and from Innovation Fund Denmark
(grant number 7045-00021B).
REFERENCES
Amor, K., Heinrichs, D. E., Frirdich, E., Ziebell, K., Johnson, R. P.,
and Whitfield, C. (2000). Distribution of core oligosaccharide types in
lipopolysaccharides from Escherichia coli. Infect. Immun. 68, 1116–1124.
doi: 10.1128/IAI.68.3.1116-1124.2000
Antibiotics Currently in Clinical Development (2014). Available online at: http://
www.pewtrusts.org/en/multimedia/data-visualizations/2014/antibiotics-
currently-in-clinical-development
Aoki, W., and Ueda, M. (2013). Characterization of antimicrobial peptides
toward the development of novel antibiotics. Pharmaceuticals 6, 1055–1081.
doi: 10.3390/ph6081055
Baba, T., Ara, T., Hasegawa, M., Takai, Y., Okumura, Y., Baba, M., et al. (2006).
Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants:
the Keio collection.Mol. Syst. Biol. 2:2006.0008. doi: 10.1038/msb4100050
Bociek, K., Ferluga, S., Mardirossian, M., Benincasa, M., Tossi, A., Gennaro, R.,
et al. (2015). Lipopolysaccharide phosphorylation by the WaaY kinase affects
the susceptibility of Escherichia coli to the human antimicrobial peptide LL-37.
J. Biol. Chem. 290, 19933–19941. doi: 10.1074/jbc.M114.634758
Brannon, J. R., Thomassin, J. L., Desloges, I., Gruenheid, S., and Le Moual,
H. (2013). Role of uropathogenic Escherichia coli OmpT in the resistance
against human cathelicidin LL-37. FEMS Microbiol. Lett. 345, 64–71.
doi: 10.1111/1574-6968.12185
Braun, V., and Bosch, V. (1972). Sequence of the murein. lipoprotein
and the attachment site of the lipid. Eur. J. Biochem. 28, 51–69.
doi: 10.1111/j.1432-1033.1972.tb01883.x
Braun, V., and Rehn, K. (1969). Chemical characterization, spatial distribution
and function of a lipoprotein (murein-lipoprotein) of the E. coli cell wall.
The specific effect of trypsin on the membrane structure. Eur. J. Biochem. 10,
426–438.
Braun, V., and Wolff, H. (1970). The murein-lipoprotein linkage in
the cell wall of Escherichia coli. Eur. J. Biochem. 14, 387–391.
doi: 10.1111/j.1432-1033.1970.tb00301.x
Caroff, M., and Karibian, D. (2003). Structure of bacterial lipopolysaccharides.
Carbohydr. Res. 338, 2431–2447. doi: 10.1016/j.carres.2003.07.010
Chang, T.-W., Lin, Y.-M., Wang, C.-F., and Liao, Y.-D. (2012). Outer
membrane lipoprotein Lpp is Gram-negative bacterial cell surface
receptor for cationic antimicrobial peptides. J. Biol. Chem. 287, 418–428.
doi: 10.1074/jbc.M111.290361
Clifton, L. A., Ciesielski, F., Skoda, M. W. A., Paracini, N., Holt, S. A., and
Lakey, J. H. (2016). The effect of lipopolysaccharide core oligosaccharide
size on the electrostatic binding of antimicrobial proteins to models of
the gram negative bacterial outer membrane. Langmuir 32, 3485–3494.
doi: 10.1021/acs.langmuir.6b00240
Cowles, C. E., Li, Y., Semmelhack,M. F., Cristea, I. M., and Silhavy, T. J. (2011). The
free and bound forms of Lpp occupy distinct subcellular locations in Escherichia
coli.Mol. Microbiol. 79, 1168–1181. doi: 10.1111/j.1365-2958.2011.07539.x
Datsenko, K. A., and Wanner, B. L. (2000). One-step inactivation of chromosomal
genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U.S.A.
97, 6640–6645. doi: 10.1073/pnas.120163297
Davies, S. C., Fowler, T., Watson, J., Livermore, D. M., and Walker
D. (2013). Annual Report of the Chief Medical Officer: infection
and the rise of antimicrobial resistance. Lancet 381, 1606–1609.
doi: 10.1016/S0140-6736(13)60604-2
Delcour, A. H. (2009). Outer membrane permeability and antibiotic resistance.
Biochim. Biophys. Acta 1794, 808–816. doi: 10.1016/j.bbapap.2008.11.005
Ebbensgaard, A., Mordhorst, H., Overgaard, M. T., Aarestrup, F. M., and
Hansen, E. B. (2018). Dissection of the antimicrobial and hemolytic activity of
Cap18: generation of Cap18 derivatives with enhanced specificity. PLoS ONE
13:e0197742. doi: 10.1371/journal.pone.0197742
Ebbensgaard, A., Mordhorst, H., Overgaard,M. T., Nielsen, C. G., Aarestrup, F.M.,
and Hansen, E. B. (2015). Comparative evaluation of the antimicrobial activity
of different antimicrobial peptides against a range of pathogenic bacteria. PLoS
ONE 10:e0144611. doi: 10.1371/journal.pone.0144611
Erridge, C., Bennett-Guerrero, E., and Poxton, I. R. (2002). Structure
and function of lipopolysaccharides. Microbes Infect. 4, 837–851.
doi: 10.1016/S1286-4579(02)01604-0
Frirdich, E., and Whitfield, C. (2005). Lipopolysaccharide inner core
oligosaccharide structure and outer membrane stability in human pathogens
belonging to the Enterobacteriaceae. J. Endotoxin Res. 11, 133–144.
doi: 10.1179/096805105X46592
Hämmerling, G., Luderitz, O., Westphal, O., and Makela, P. H. (1971). Structural
investigations on the core polysaccharide of Escherichia coli 0100. Eur. J.
Biochem. 22, 331–344. doi: 10.1111/j.1432-1033.1971.tb01549.x
Hampton, T. (2013). Report reveals scope of US antibiotic resistance threat. JAMA
310, 1661–1663. doi: 10.1001/jama.2013.280695
Heinrichs, D. E., Monteiro, M. A., Perry, M. B., and Whitfield, C. (1998a). The
assembly system for the lipopolysaccharide R2 core-type of Escherichia coli is a
hybrid of those found in Escherichia coli K-12 and Salmonella enterica. J. Biol.
Chem. 273, 8849–8859. doi: 10.1074/jbc.273.15.8849
Heinrichs, D. E., Yethon, J. A., and Whitfield, C. (1998b). Molecular basis
for structural diversity in the core regions of the lipopolysaccharides
of Escherichia coli and Salmonella enterica. Mol. Microbiol. 30, 221–232.
doi: 10.1046/j.1365-2958.1998.01063.x
Hirota, Y., Suzuki, H., Nishimura, Y., and Yasuda, S. (1977). On the process of
cellular division in Escherichia coli: a mutant of E. coli lacking a murein-
lipoprotein. Proc. Natl. Acad. Sci. U.S.A. 74, 1417–1420.
Hritonenko, V., and Stathopoulos, C. (2007). Omptin proteins: an expanding
family of outermembrane proteases in Gram-negative Enterobacteriaceae.Mol.
Membr. Biol. 24, 395–406. doi: 10.1080/09687680701443822
Jenssen, H., Hamill, P., andHancock, R. E.W. (2006). Peptide antimicrobial agents.
Clin. Microbiol. Rev. 19, 491–511. doi: 10.1128/CMR.00056-05
Kanj, S. S., and Kanafani, Z. A. (2011). Current concepts in antimicrobial therapy
against resistant gram-negative organisms: extended-spectrum beta-lactamase-
producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and
multidrug-resistant Pseudomonas aeruginosa. Mayo Clin. Proc. 86, 250–259.
doi: 10.4065/mcp.2010.0674
Kowata, H., Tochigi, S., Kusano, T., and Kojima, S. (2016). Quantitative
measurement of the outer membrane permeability in Escherichia coli lpp and
tol-pal mutants defines the significance of Tol-Pal function for maintaining
drug resistance. J. Antibiot. 69, 863–870. doi: 10.1038/ja.2016.50
Kramer, R. A., Vandeputte-Rutten, L., De Roon, G. J., Gros, P., Dekker, N., and
Egmond, M. R. (2001). Identification of essential acidic residues of outer
membrane protease OmpT supports a novel active site. FEBS Lett. 505,
426–430. doi: 10.1016/S0014-5793(01)02863-0
Kramer, R. A., Zandwijken, D., Egmond, M. R., and Dekker, N. (2000).
In vitro folding, purification and characterization of Escherichia coli
outer membrane protease OmpT. Eur. J. Biochem. 267, 885–893.
doi: 10.1046/j.1432-1327.2000.01073.x
McNicholas, S., Potterton, E., Wilson, K. S., and Noble, M. E. M. (2011). Presenting
your structures: the CCP4mg molecular-graphics software. Acta Crystallogr.
Sect. D Biol. Crystallogr. 67, 386–394. doi: 10.1107/S0907444911007281
Frontiers in Microbiology | www.frontiersin.org 12 September 2018 | Volume 9 | Article 2153
Ebbensgaard et al. Lipopolysaccharides Determine Sensitivity to AMPs
Neidhardt, F., and Umbarger, H. (1996). “Chemical composition of Escherichia
coli,” in Escherichia coli and Salmonella: Cellular and Molecular Biology, eds
F. Neidhardt, C. R. Curtiss, J. I. Ingraham, E. C. C. Lin, K. B. Low, and B.
Magasanik (Washington, DC: ASM Press), 13–16.
Nikaido, H. (1996). “Outer membrane,” in Escherichia coli and Salmonella: Cellular
and Molecular Biology, eds F. Neidhardt, C. R. Curtiss, J. I. Ingraham, E. C. C.
Lin, K. B. Low, and B. Magasanik (Washington, DC: ASM Press), 29–47.
Nikaido, H. (2003). Molecular basis of bacterial outer membrane permeability
revisited.Microbiol. Mol. Biol. Rev. 67, 593–656. doi: 10.1128/MMBR.67.4.593
Peschel, A., and Sahl, H. G. (2006). The co-evolution of host cationic
antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4,
529–536. doi: 10.1038/nrmicro1441
Raetz, C. R. H., and Whitfield, C. (2002). Lipopolysaccharide endotoxins. Annu.
Rev. Biochem. 71, 635–700. doi: 10.1146/annurev.biochem.71.110601.135414
Roy, A., Kucukural, A., and Zhang, Y. (2010). I-TASSER: a unified platform for
automated protein structure and function prediction. Nat. Protoc. 5, 725–738.
doi: 10.1038/nprot.2010.5
Savage, P. B. (2001). Multidrug-resistant bacteria: overcoming antibiotic
permeability barriers of Gram-negative bacteria. Ann. Med. 33, 167–171.
doi: 10.3109/07853890109002073
Schmidt, G., Fromme, I., and Mayer, H. (1970). Immunochemical studies on core
lipopolysaccharides of enterobacteriaceae of different genera. Eur. J. Biochem.
14, 357–366. doi: 10.1111/j.1432-1033.1970.tb00297.x
Schmidt, G., Jann, B., and Jann, K. (1969). Immunochemistry of R
lipopolysaccharides of Escherichia coli. Different core regions in the
lipopolysaccharides of O group 8. Eur. J. Biochem. 10, 501–510.
Schmidt, G., Jann, B., and Jann, K. (1974). Genetic and immunochemical
studies on Escherichia coli O14:K7:H-. Eur. J. Biochem. 42, 303–309.
doi: 10.1111/j.1432-1033.1974.tb03340.x
Schneck, E., Schubert, T., Konovalov, O. V., Quinn, B. E., Gutsmann,
T., Brandenburg, K., et al. (2010). Quantitative determination of ion
distributions in bacterial lipopolysaccharide membranes by grazing-
incidence X-ray fluorescence. Proc. Natl. Acad. Sci. U.S.A. 107, 9147–9151.
doi: 10.1073/pnas.0913737107.
Stumpe, S., Schmid, R., Stephens, D. L., Georgiou, G., and Bakker, E. P. (1998).
Identification of OmpT as the protease that hydrolyzes the antimicrobial
peptide protamine before it enters growing cells of Escherichia coli. J. Bacteriol.
180, 4002–4006.
Sugimura, K., and Nishihara, T. (1988). Purification, characterization, and primary
structure of Escherichia coli protease VII with specificity for paired basic
residues: identity of protease VII and OmpT. J. Bacteriol. 170, 5625–5632.
Suzuki, H., Nishimura, Y., Yasuda, S., Nishimura, A., Yamada, M., and Hirota,
Y. (1978). Murein-lipoprotein of Escherichia coli: a protein involved in the
stabilization of bacterial cell envelope. MGG Mol. Gen. Genet. 167, 1–9.
doi: 10.1007/BF00270315
Thomassin, J. L., Brannon, J. R., Gibbs, B. F., Gruenheid, S., and Le Moual,
H. (2012). OmpT outer membrane proteases of enterohemorrhagic
and enteropathogenic Escherichia coli contribute differently to the
degradation of human LL-37. Infect. Immun. 80, 483–492. doi: 10.1128/IAI.
05674-11
Vaara, M. (1992). Agents that increase the permeability of the outer membrane.
Microbiol. Rev. 56, 395–411.
Vaara, M. (1993). Antibiotic-supersusceptible mutants of Escherichia coli and
Salmonella typhimurium. Antimicrob. Agents Chemother. 37, 2255–2260.
Vinogradov, E. V., Van Der Drift, K., Thomas-Oates, J. E., Meshkov, S., Brade,
H., and Holst, O. (1999). The structures of the carbohydrate backbones
of the lipopolysaccharides from Escherichia coli rough mutants F470 (R1
core type) and F576 (R2 core type). Eur. J. Biochem. 261, 629–639.
doi: 10.1046/j.1432-1327.1999.00280.x
Wikler, M. A., Cockerill, F. R., Bush, K., Dudley, M. N., Eliopoulos, G. M., Hardy,
D. J., et al. (2009). Methods for Dilution Antimicrobial Susceptibility Tests
for Bacteria that Grow Aerobically; Approved Standard, 8th Edn. Wayne, PA:
Clinical and Laboratory Standards Institute
World Health Organization (2014). Antimicrobial Resistance: Global Report
on Surveillance 2014. Available oline at: http://www.who.int/drugresistance/
documents/surveillancereport/en/
Yeaman, M. R., and Yount, N. Y. (2003). IP_Mechanisms of antimicrobial
peptide action and resistance. Pharmacol. Rev. 55, 27–55. doi: 10.1124/pr.
55.1.2
Yethon, J. A., Heinrichs, D. E., Monteiro, M. A., Perry, M. B., and
Whitfield, C. (1998). Involvement of waaY, waaQ, and waaP in the
modification of Escherichia coli lipopolysaccharide and their role in the
formation of a stable outer membrane. J. Biol. Chem. 273, 26310–26316
doi: 10.1074/jbc.273.41.26310
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2018 Ebbensgaard, Mordhorst, Aarestrup and Hansen. This is an open-
access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) and the copyright owner(s) are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Microbiology | www.frontiersin.org 13 September 2018 | Volume 9 | Article 2153
